Home LiteratureArticle Details
PMID: 17032987 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places.

JAMA ·Vol. 296 ·No. 14 ·2006-10-11 ·Pages 1742-8

Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZ, Barnes M, Fardon TC, McFarlane L, Magee GJ, Lipworth BJ

Abstract

Scotland prohibited smoking in confined public places on March 26, 2006. To investigate the association of smoke-free legislation with symptoms, pulmonary function, and markers of inflammation of bar workers. This prospective observational study was conducted in Tayside, Scotland from February-June 2006. One hundred five nonasthmatic and asthmatic nonsmoking bar workers were initially enrolled, of whom 77 completed the study per protocol. Respiratory and sensory symptoms, spirometry measurements, serum cotinine levels, peripheral inflammatory cell count, asthma quality-of-life scores, and exhaled nitric oxide levels were evaluated before and after introduction of the smoking ban. For the per-protocol analysis, the percentage of bar workers with respiratory and sensory symptoms decreased from 79.2% (n = 61) before the smoke-free policy to 53.2% (n = 41) (total change, -26%; 95% confidence interval [CI], -13.8% to -38.1%; P<.001) and 46.8% (n = 38) (-32.5%; 95% CI, -19.8% to -45.2%; P<.001) 1 and 2 months afterward. Forced expiratory volume in the first second increased from 96.6% predicted to 104.8% (change, 8.2%; 95% CI, 3.9% to 12.4%; P<.001) and then 101.7% (change, 5.1%; 95% CI, 2.1% to 8.0%; P = .002), and serum cotinine levels decreased from 5.15 ng/mL to 3.22 ng/mL (change, -1.93 ng/mL; 95% CI, -2.83 to -1.03 ng/mL; P<.001) and then 2.93 ng/mL (-2.22 ng/mL; 95% CI, -3.10 to -1.34 ng/mL; P<.001). The total white blood cell and neutrophil count was reduced from 7610 to 6980 cells/microL at 2 months (-630 cells/muL; 95% CI, -1010 to -260 cells/microL; P = .002) and from 4440 to 4030 cells/microL (-410 cells/microL; 95% CI, -740 to -90 cells/microL; P = .03), respectively. Asthmatic bar workers also had less airway inflammation, with a reduction in exhaled nitric oxide from 34.3 parts per billion (ppb) to 27.4 ppb 1 month after the ban (0.8-fold change; 95% CI, 0.67 to 0.96 ppb; P = .04), and Juniper quality-of-life scores increased from 80.2 to 87.5 points (7.3 points; 95% CI, 0.1 to 14.6 points; P = .049). Smoke-free legislation was associated with significant early improvements in symptoms, spirometry measurements, and systemic inflammation of bar workers. Asthmatic bar workers also had reduced airway inflammation and improved quality of life.

MeSH Terms
Adult Asthma C-Reactive Protein/metabolism Female Humans Inflammation Leukocyte Count Male Nitric Oxide/metabolism Occupational Health Prospective Studies Quality of Life Respiration Respiratory Function Tests Restaurants Rhinitis Scotland Smoking/legislation & jurisprudence Tobacco Smoke Pollution/adverse effects,prevention & control
Chemicals
Tobacco Smoke Pollution Nitric Oxide C-Reactive Protein
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Menzies Daniel
Asthma and Allergy Research Group, Department of Medicine, Ninewells Hospital and Medical School, Dundee, Scotland. d.menzies@dundee.ac.uk
Nair Arun
Williamson Peter A
Schembri Stuart
Al-Khairalla Mudher Z H
Barnes Martyn
Fardon Tom C
McFarlane Lesley
Magee Gareth J
Lipworth Brian J
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
Published
2006-10-11
Pages
1742-8
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com